← SynDRA
CGS-20625
SynDRA canonical compound SYN0087291 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | GABRA6 |
|---|
| Mechanism of action | Benzodiazepine receptor agonist |
|---|
All known targets
- GABRA1
- GABRA2
- GABRA3
- GABRA4
- GABRA5
- GABRA6
Mechanisms of action (all sources)
- Benzodiazepine receptor agonist
- GABA benzodiazepine site receptor partial agonist
Cross-references
Look up CGS-20625 in the interactive SynDRA portal →